ICGEB

Recbio appeared at the 14th China (Taizhou) International Pharmaceutical Fair

Retrieved on: 
Tuesday, October 24, 2023

TAIZHOU, China, Oct. 24, 2023 /PRNewswire/ -- From October 19 to 22, the 14th China (Taizhou) International Pharmaceutical Fair, sponsored by the China Chamber of International Commerce and hosted by the Taizhou Municipal People's Government and Jiangsu Branch of the China Council for the Promotion of International Trade, was successfully held in Taizhou China Pharmaceutical City.

Key Points: 
  • TAIZHOU, China, Oct. 24, 2023 /PRNewswire/ -- From October 19 to 22, the 14th China (Taizhou) International Pharmaceutical Fair, sponsored by the China Chamber of International Commerce and hosted by the Taizhou Municipal People's Government and Jiangsu Branch of the China Council for the Promotion of International Trade, was successfully held in Taizhou China Pharmaceutical City.
  • The theme of this year's exhibition is "New adjuvants, open and win-win situation, taking root in the China Pharmaceutical City, and going to the world".
  • The new adjuvant platform of Recbio has three characteristics: systematization, industrialization, and continuous innovation.
  • Benefiting from the leading new adjuvant core technology and the near industrialization of the heavy pipeline, the international layout of Recbio is accelerating.

Forcefield Therapeutics presents positive preclinical data at the 2022 Scientific Sessions of American Heart Association

Retrieved on: 
Monday, November 7, 2022

London UK, 7 November 2022 Forcefield Therapeutics (Forcefield) Ltd, a pioneer of best-in-class therapeutics to protect heart function by arresting the loss of cardiomyocytes following myocardial infarction, has presented positive preclinical data on three proteins identified by the FunSel platform which have potential to preserve heart function following a heart attack.

Key Points: 
  • London UK, 7 November 2022 Forcefield Therapeutics (Forcefield) Ltd, a pioneer of best-in-class therapeutics to protect heart function by arresting the loss of cardiomyocytes following myocardial infarction, has presented positive preclinical data on three proteins identified by the FunSel platform which have potential to preserve heart function following a heart attack.
  • The paper presented preclinical data outlining the mechanisms of three proteins identified by FunSel, Forcefields protein search engine.
  • It has been further developed by Mauro Giacca, Professor of Cardiovascular Sciences at Kings College London and co-founder of Forcefield Therapeutics and supported by the British Heart Foundation.
  • Forcefield Therapeutics Ltd (Forcefield Tx) is a pioneer of best-in-class therapeutics to retain heart function via protection of cardiomyocytes.

Researchers identify three proteins which have the potential to prevent heart failure after heart attack

Retrieved on: 
Wednesday, August 31, 2022

Heart failure is the primary cause of death and disability globally, affecting approximately 64 million people worldwide according to the British Heart Foundation.

Key Points: 
  • Heart failure is the primary cause of death and disability globally, affecting approximately 64 million people worldwide according to the British Heart Foundation.
  • According to the British Heart Foundation, one person every five minutes is admitted to hospital with a heart attack in the UK.
  • Heart failure after a heart attack is caused by the irreversible loss of cardiac cells, hence the need to develop effective therapies to prevent the death of these cells.
  • Prof. Giacca added: Any of the three proteins we have identified can be administered immediately after a heart attack to minimise cardiac damage and thus prevent heart failure.

IUSTC Annual Conference: Information Exchanges Promote Global Collaboration

Retrieved on: 
Wednesday, December 22, 2021

Representatives of IUSTC members, presented their congratulations at the opening ceremony, summarized their past sci-tech cooperation, especially with S&T Daily and looked forward to more exchanges among IUSTC members.

Key Points: 
  • Representatives of IUSTC members, presented their congratulations at the opening ceremony, summarized their past sci-tech cooperation, especially with S&T Daily and looked forward to more exchanges among IUSTC members.
  • Since its establishment, the IUSTC has played its important role in promoting global sci-tech exchanges and cooperation, improving the efficiency of sci-tech information, communication, and enhancing media influence.
  • Through digital media platforms, public engagement, and media relations, ICGEB contributes to promote international sci-tech cooperation together with IUSTC."
  • Therefore to help promote the spread of scientific and technological information, the IUSTC Secretariat issued four working initiatives for IUSTC members.

IUSTC Annual Conference: Information Exchanges Promote Global Collaboration

Retrieved on: 
Wednesday, December 22, 2021

Representatives of IUSTC members, presented their congratulations at the opening ceremony, summarized their past sci-tech cooperation, especially with S&T Daily and looked forward to more exchanges among IUSTC members.

Key Points: 
  • Representatives of IUSTC members, presented their congratulations at the opening ceremony, summarized their past sci-tech cooperation, especially with S&T Daily and looked forward to more exchanges among IUSTC members.
  • Since its establishment, the IUSTC has played its important role in promoting global sci-tech exchanges and cooperation, improving the efficiency of sci-tech information, communication, and enhancing media influence.
  • Through digital media platforms, public engagement, and media relations, ICGEB contributes to promote international sci-tech cooperation together with IUSTC."
  • Therefore to help promote the spread of scientific and technological information, the IUSTC Secretariat issued four working initiatives for IUSTC members.